Sonova Holding (OTCMKTS:SONVY) Short Interest Down 94.2% in June
by Scott Moore · The Cerbat GemSonova Holding (OTCMKTS:SONVY – Get Free Report) was the target of a large decrease in short interest in the month of June. As of June 15th, there was short interest totaling 3,402 shares, a decrease of 94.2% from the May 31st total of 58,424 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average trading volume of 40,770 shares, the short-interest ratio is presently 0.1 days.
Sonova Price Performance
OTCMKTS:SONVY traded up $0.31 during mid-day trading on Thursday, hitting $48.05. 19,187 shares of the company traded hands, compared to its average volume of 23,576. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.43 and a current ratio of 1.75. The stock’s fifty day moving average price is $48.59 and its 200-day moving average price is $49.90. Sonova has a one year low of $42.26 and a one year high of $61.09.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on SONVY. Jefferies Financial Group downgraded shares of Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday, March 18th. BNP Paribas Exane upgraded shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research report on Tuesday, March 10th. Citigroup restated a “sell” rating on shares of Sonova in a report on Wednesday, May 13th. Finally, Morgan Stanley raised shares of Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy”.
Read Our Latest Stock Analysis on Sonova
About Sonova
Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.
Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.